GUANGZHOU KANGYIXIN PHARMACEUTICAL TECHNOLOGY CO., LTD. – Trademark Portfolio
Entity Type: 99
GUANGZHOU KANGYIXIN PHARMACEUTICAL TECHNOLOGY CO., LTD. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include IBESDINA. The owner is based in GUANGZHOU CITY.
ROOM 202, BUILDING 4, NO. 61 FURONG
AVENUE, NORTH, XINZHUANG VILLAGE, SHILING TOWN,, HUADU DISTRICT,
GUANGZHOU CITY 510860 , CN
Showing of trademarks Trademarks
Trademark Classifications
GUANGZHOU KANGYIXIN PHARMACEUTICAL TECHNOLOGY CO., LTD.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does GUANGZHOU KANGYIXIN PHARMACEUTICAL TECHNOLOGY CO., LTD. have?
GUANGZHOU KANGYIXIN PHARMACEUTICAL TECHNOLOGY CO., LTD. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does GUANGZHOU KANGYIXIN PHARMACEUTICAL TECHNOLOGY CO., LTD. file in?
GUANGZHOU KANGYIXIN PHARMACEUTICAL TECHNOLOGY CO., LTD. files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are GUANGZHOU KANGYIXIN PHARMACEUTICAL TECHNOLOGY CO., LTD.'s most well-known trademarks?
GUANGZHOU KANGYIXIN PHARMACEUTICAL TECHNOLOGY CO., LTD.'s registered trademark portfolio includes well-known marks such as IBESDINA. These are among 1 currently registered trademark in the portfolio.
What is GUANGZHOU KANGYIXIN PHARMACEUTICAL TECHNOLOGY CO., LTD.'s trademark registration success rate?
GUANGZHOU KANGYIXIN PHARMACEUTICAL TECHNOLOGY CO., LTD. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.